165 related articles for article (PubMed ID: 29482530)
1. Deficiency of the BMP Type I receptor ALK3 partly protects mice from anemia of inflammation.
Gallitz I; Lofruthe N; Traeger L; Bäumer N; Hoerr V; Faber C; Kuhlmann T; Müller-Tidow C; Steinbicker AU
BMC Physiol; 2018 Feb; 18(1):3. PubMed ID: 29482530
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice.
Wang CY; Xiao X; Bayer A; Xu Y; Dev S; Canali S; Nair AV; Masia R; Babitt JL
Hepatology; 2019 Dec; 70(6):1986-2002. PubMed ID: 31127639
[TBL] [Abstract][Full Text] [Related]
3. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.
Canali S; Core AB; Zumbrennen-Bullough KB; Merkulova M; Wang CY; Schneyer AL; Pietrangelo A; Babitt JL
Endocrinology; 2016 Mar; 157(3):1146-62. PubMed ID: 26735394
[TBL] [Abstract][Full Text] [Related]
4. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.
Wang CY; Core AB; Canali S; Zumbrennen-Bullough KB; Ozer S; Umans L; Zwijsen A; Babitt JL
Blood; 2017 Jul; 130(1):73-83. PubMed ID: 28438754
[TBL] [Abstract][Full Text] [Related]
5. ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2.
Traeger L; Gallitz I; Sekhri R; Bäumer N; Kuhlmann T; Kemming C; Holtkamp M; Müller JC; Karst U; Canonne-Hergaux F; Muckenthaler MU; Bloch DB; Olschewski A; Bartnikas TB; Steinbicker AU
Free Radic Biol Med; 2018 Dec; 129():127-137. PubMed ID: 30227271
[TBL] [Abstract][Full Text] [Related]
6. HFE and ALK3 act in the same signaling pathway.
Traeger L; Schnittker J; Dogan DY; Oguama D; Kuhlmann T; Muckenthaler MU; Krijt J; Urzica EI; Steinbicker AU
Free Radic Biol Med; 2020 Nov; 160():501-505. PubMed ID: 32861780
[TBL] [Abstract][Full Text] [Related]
7. The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6.
Mayeur C; Lohmeyer LK; Leyton P; Kao SM; Pappas AE; Kolodziej SA; Spagnolli E; Yu B; Galdos RL; Yu PB; Peterson RT; Bloch DB; Bloch KD; Steinbicker AU
Blood; 2014 Apr; 123(14):2261-8. PubMed ID: 24501215
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice.
Steinbicker AU; Bartnikas TB; Lohmeyer LK; Leyton P; Mayeur C; Kao SM; Pappas AE; Peterson RT; Bloch DB; Yu PB; Fleming MD; Bloch KD
Blood; 2011 Oct; 118(15):4224-30. PubMed ID: 21841161
[TBL] [Abstract][Full Text] [Related]
9. Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3.
Dogan DY; Urzica EI; Hornung I; Kastl P; Oguama D; Fette FM; Nguyen LH; Rosenbauer F; Zacharowski K; Klingmüller U; Gradhand E; von Knethen A; Popp R; Fleming I; Schrader L; Steinbicker AU
Blood Adv; 2024 Jun; 8(11):2870-2879. PubMed ID: 38588481
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus.
Gardenghi S; Renaud TM; Meloni A; Casu C; Crielaard BJ; Bystrom LM; Greenberg-Kushnir N; Sasu BJ; Cooke KS; Rivella S
Blood; 2014 Feb; 123(8):1137-45. PubMed ID: 24357729
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin and the BMP-SMAD pathway: An unexpected liaison.
Silvestri L; Nai A; Dulja A; Pagani A
Vitam Horm; 2019; 110():71-99. PubMed ID: 30798817
[TBL] [Abstract][Full Text] [Related]
12. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli.
Huang H; Constante M; Layoun A; Santos MM
Blood; 2009 Apr; 113(15):3593-9. PubMed ID: 19204324
[TBL] [Abstract][Full Text] [Related]
13. The hemochromatosis protein HFE signals predominantly via the BMP type I receptor ALK3 in vivo.
Traeger L; Enns CA; Krijt J; Steinbicker AU
Commun Biol; 2018; 1():65. PubMed ID: 30271947
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.
Steinbicker AU; Sachidanandan C; Vonner AJ; Yusuf RZ; Deng DY; Lai CS; Rauwerdink KM; Winn JC; Saez B; Cook CM; Szekely BA; Roy CN; Seehra JS; Cuny GD; Scadden DT; Peterson RT; Bloch KD; Yu PB
Blood; 2011 May; 117(18):4915-23. PubMed ID: 21393479
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6.
Canali S; Wang CY; Zumbrennen-Bullough KB; Bayer A; Babitt JL
Am J Hematol; 2017 Nov; 92(11):1204-1213. PubMed ID: 28815688
[TBL] [Abstract][Full Text] [Related]
16. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.
Herhaus L; Al-Salihi MA; Dingwell KS; Cummins TD; Wasmus L; Vogt J; Ewan R; Bruce D; Macartney T; Weidlich S; Smith JC; Sapkota GP
Open Biol; 2014 May; 4(5):140065. PubMed ID: 24850914
[TBL] [Abstract][Full Text] [Related]
17. Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia.
Xiao X; Moschetta GA; Xu Y; Fisher AL; Alfaro-Magallanes VM; Dev S; Wang CY; Babitt JL
Blood; 2023 Jan; 141(4):422-432. PubMed ID: 36322932
[TBL] [Abstract][Full Text] [Related]
18. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver.
Kautz L; Meynard D; Monnier A; Darnaud V; Bouvet R; Wang RH; Deng C; Vaulont S; Mosser J; Coppin H; Roth MP
Blood; 2008 Aug; 112(4):1503-9. PubMed ID: 18539898
[TBL] [Abstract][Full Text] [Related]
19. AMPK Serves as a Therapeutic Target Against Anemia of Inflammation.
Wang M; Xin H; Tang W; Li Y; Zhang Z; Fan L; Miao L; Tan B; Wang X; Zhu YZ
Antioxid Redox Signal; 2017 Aug; 27(5):251-268. PubMed ID: 27923278
[TBL] [Abstract][Full Text] [Related]
20. HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.
Wu XG; Wang Y; Wu Q; Cheng WH; Liu W; Zhao Y; Mayeur C; Schmidt PJ; Yu PB; Wang F; Xia Y
Blood; 2014 Aug; 124(8):1335-43. PubMed ID: 24904118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
